650 597

Cited 139 times in

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma

Authors
 Hyun GooWoo  ;  Eun Sung Park  ;  Jae Hee Cheon  ;  Ju Han Kim  ;  Ju-Seog Lee  ;  BumJoon Park  ;  Won Kim  ;  Su Cheol Park  ;  YoungJin Chung  ;  Byeong Gwan Kim  ;  Jung-HwanYoon  ;  Hyo-Suk Lee  ;  ChungYong Kim  ;  Nam-JoonYi  ;  Kyung-Suk Suh  ;  Kuhn Uk Lee  ;  In-Sun Chu  ;  Tania Roskams  ;  Snorri S.Thorgeirsson  ;  YoonJun Kim 
Citation
 CLINICAL CANCER RESEARCH, Vol.14(7) : 2056-2064, 2008 
Journal Title
CLINICAL CANCER RESEARCH
ISSN
 1078-0432 
Issue Date
2008
MeSH
Biomarkers, Tumor/genetics* ; Carcinoma, Hepatocellular/genetics* ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; Gene Expression* ; Gene Expression Profiling ; Hepatitis B virus ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/pathology ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/genetics* ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Neoplasm Recurrence, Local/genetics* ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/virology ; Oligonucleotide Array Sequence Analysis ; Prognosis
Keywords
Biomarkers, Tumor/genetics* ; Carcinoma, Hepatocellular/genetics* ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; Gene Expression* ; Gene Expression Profiling ; Hepatitis B virus ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/pathology ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/genetics* ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Neoplasm Recurrence, Local/genetics* ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/virology ; Oligonucleotide Array Sequence Analysis ; Prognosis
Abstract
PURPOSE: The poor prognosis of hepatocellular carcinoma (HCC) is, in part, due to the high rate of recurrence even after "curative resection" of tumors. Therefore, it is axiomatic that the development of an effective prognostic prediction model for HCC recurrence after surgery would, at minimum, help to identify in advance those who would most benefit from the treatment, and at best, provide new therapeutic strategies for patients with a high risk of early recurrence.

EXPERIMENTAL DESIGN: For the prediction of the recurrence time in patients with HCC, gene expression profiles were generated in 65 HCC patients with hepatitis B infections.

RESULT: Recurrence-associated gene expression signatures successfully discriminated between patients at high-risk and low-risk of early recurrence (P=1.9 x 10(-6), log-rank test). To test the consistency and robustness of the recurrence signature, we validated its prognostic power in an independent HCC microarray data set. CD24 was identified as a putative biomarker for the prediction of early recurrence. Genetic network analysis suggested that SP1 and peroxisome proliferator-activated receptor-alpha might have regulatory roles for the early recurrence of HCC.

CONCLUSION: We have identified a gene expression signature that effectively predicted early recurrence of HCC independent of microarray platforms and cohorts, and provided novel biological insights into the mechanisms of tumor recurrence
Files in This Item:
T200800478.pdf Download
DOI
10.1158/1078-0432.CCR-07-1473
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Park, Eun Sung(박은성)
Cheon, Jae Hee(천재희) ORCID logo https://orcid.org/0000-0002-2282-8904
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/106659
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links